Thermo Fisher Scientific declares $0.47 dividend

Thermo Fisher Scientific announced a $0.47 per share quarterly dividend, matching its prior payment. The forward yield is 0.28%. The dividend is payable on January 15, with a record date of December 15 and ex-dividend date of December 15.

Original reporting
Published Nov 6, 2026, 3:23 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 6:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Thermo Fisher Scientific declares $0.47 dividend — source image
Decision brief

The 30-second read

$TMONeutralMed
01

Why it matters

The $0.47 dividend aligns with prior payouts, indicating stable cash flow but offering limited upside for income traders.

02

Market read

A routine dividend announcement with modest yield; modest relevance for income‑oriented strategies.

03

What to watch

Potential tax considerations for dividend‑receiving investors and the impact of upcoming earnings guidance.

Relevance 5/10Novelty 5/10Timing: ex‑dividend on Dec 15, payable Jan 15

Background

Thermo Fisher Scientific, a leading life‑sciences equipment and services provider, regularly issues quarterly dividends.

Company-level read

Ticker impact

$TMONeutralHigh confidence
Context

Thermo Fisher Scientific announced a quarterly dividend of $0.47 per share, payable Jan. 15 with record date Dec. 15.

Expected impact

likely slight upward pressure as the ex‑div date approaches

Evidence & confidence

Dividend announcements are routine but can create modest buying interest, especially for yield‑seeking traders.

Market effects

May slightly boost the broader life‑sciences sector as dividend‑seeking investors rotate.

Minimal impact on US markets; primarily relevant to dividend‑focused funds.

Limited global relevance; only affects investors tracking US biotech dividend yields.

Counterpoint

Some traders may view the modest yield (0.28%) as insufficient to justify a position, preferring growth over income.

Key entities

  • Thermo Fisher Scientific

    US‑listed life‑sciences company (ticker TMO).

Related articles

$TMOMed

Thermo Fisher Scientific Replenishes Buyback Capacity to $5 Billion

Thermo Fisher Scientific (TMO) authorized up to $5B in new stock repurchases, replacing a prior authorization with $1B remaining. The company spent $4B on buybacks in 2026's first nine months, with no purchases in Q3. Operating cash flow increased to $5.867B for the period, with $4.618B in free cash flow. The new authorization complements acquisitions, dividends, and debt obligations.